Post-traumatic stress disorder (PTSD) is common in military veterans but can affect anyone who has suffered or witnessed an ...

The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava ...

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

(IN BRIEF) Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for patients with PD-L1-high, advanced, or metastatic non-small cell ...